Roger lamb, Healthcare sector Manager at GS1 UK, examines the issue in this in-depth article. The previous success stories of these technologies being implemented show that other healthcare institutions should be following suit to increase efficiency, reduce costs and, most importantly, improve patient safety.
While many believe chemical indicators may fall short of compliance with global regulations and industry best practices, these devices have, over time, migrated to last-mile cold chain applications in the life science market. Jeff Hawkins of Sensitech Inc. explains the considerations for temperature indicator usage.
Oliver Naucke of Uhlmann Pac-Systeme GmbH explains the concept of – “7×4 Box – My week´s medicine”. To ensure consistent compliance, especially in the case of chronically ill and older people, 7×4 Pharma GmbH commenced a pilot project with the compulsory health insurance AOK Berlin in 2009 to supply patients with individually-packed blisters with their weekly medication.
There are approximately 881,000 malaria-related deaths every year. Drs Nadia elMasry and Chemtai Kipkeu show how Novartis Pharma AG is doing in the fight against malaria.
Anne Dallison of Design Cognition Ltd argues that this change will dramatically increase the safety and sense of security of the many Braille users in Europe.
This article by Richard Burhouse of Payne Security discusses the issue of counterfeit drugs, outlines current legislation and discusses the latest secure packaging technologies and their unique benefits.
Chris Johnson of CYPAK writes on how products conforming to IEEE 11073-10472 and Continua Health Alliance will have a major impact on the way pharmaceuticals are packaged and delivered in future.
Anton Gerdenitsch of Fresenius Kabi evaluates the proposition that, when emulsions are carefully designed with respect to the target and route of administration, they may provide one solution to some of the delivery problems posed by new classes of active molecules, such as peptides, proteins, genes, and oligonucleotides. They may also extend the therapeutic potential of established drugs.
Nathan Kohner of Almac Group explains that a process for the efficient visibility of the success of temperature control increases detectability, and therefore reduces the risk factor.